D-谷氨酸二叔丁酯盐酸盐 | 172793-31-6

• 物质功能分类: 生物化工 - 氨基酸及其衍生物 - 天然氨基酸及其衍生物
• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 中文名称: D-谷氨酸二叔丁酯盐酸盐
• 中文别名: D-谷氨酸二叔丁基酯盐酸盐
• 英文名称: di-tert-butyl D-glutamate hydrochloride
• 英文别名: D-glutamic acid di-tert-butyl ester hydrochloride；(R)-Di-tert-butyl 2-aminopentanedioate hydrochloride；ditert-butyl (2R)-2-aminopentanedioate;hydrochloride
• CAS: 172793-31-6
• 化学式: C₁₃H₂₅NO₄*ClH
• 分子量: 295.807
• InChiKey: LFEYMWCCUAOUKZ-SBSPUUFOSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.2
• 重原子数：
  19
• 可旋转键数：
  8
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.85
• 拓扑面积：
  78.6
• 氢给体数：
  2
• 氢受体数：
  5

安全信息

• 海关编码：
  2922499990
• 危险性防范说明：
  P261,P305+P351+P338
• 危险性描述：
  H302,H315,H319,H335

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Product Name: H-D-Glu(otbu)-otbu hcl
Synonyms:

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

---

Section 3. Composition/information on ingredients.
Ingredient name: H-D-Glu(otbu)-otbu hcl
CAS number: 172793-31-6

---

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels.
Storage:

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C13H25NO4.ClH
Molecular weight: 295.8

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides, hydrogen chloride.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  D-谷氨酸二叔丁酯盐酸盐 在 sodium chlorite 、 sodium dihydrogenphosphate 、 2-甲基-2-丁烯 、 benzotriazol-1-yloxyl-tris-(pyrrolidino)-phosphonium hexafluorophosphate 、 potassium carbonate 、 三乙胺 作用下， 以 二氯甲烷 、 N,N-二甲基乙酰胺 、 叔丁醇 为溶剂， 反应 51.25h， 生成 di-tert-butyl N-[[4-(2,4-diaminoquinazoline-6-yl)methyl]benzoyl]-D-glutamate
  参考文献：
  名称：

  设计和合成包含桥接酯基的二氢叶酸还原酶抑制剂。在小鼠结肠炎模型中的评估。

  摘要：

  克罗恩氏病是一种慢性炎症性肠病，其特征是小肠和大肠都发炎。甲氨蝶呤（MTX）是一种经典的二氢叶酸还原酶（DHFR）抑制剂，近年来已被用作克罗恩病患者的治疗剂。我们试图开发结构类似于MTX的抗叶酸药，该药可有效减轻结肠炎的小鼠疾病模型中的炎症。合成了在分子中心部分包​​含酯桥的四种经典DHFR抑制剂。这些抗叶酸剂是源自大鼠的DHFR酶的有效抑制剂。还体外测试了它们抑制小鼠脾淋巴细胞诱导的增殖的能力。仅在微摩尔范围内才能达到抑制细胞增殖的作用，而MTX在低纳摩尔浓度下有效。选择一种DHFR抑制剂（1），其rlDHFR的IC（50）值比甲氨蝶呤高约8倍，用于小鼠实验性结肠炎模型的体内实验。该化合物在局部给药后表现出明显的抗炎作用，与糖皮质激素布地奈德所达到的作用相当。在该模型中评估了三个参数：髓过氧化物酶活性，结肠重量和炎症评分。在所有三个炎症参数中均观察到化合物1的体内有益作用（15 mg /（kg

  DOI：

  10.1021/jm021062y

文献信息

• [EN] INHIBITORS OF GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMYLASE<br/>[FR] INHIBITEURS DE LA TRANSFORMYLASE DE LA GLYCINAMIDE RIBONUCLEOTIDE
  申请人：SCRIPPS RESEARCH INST

  公开号：WO2003087065A1

  公开（公告）日：2003-10-23

  Potent human inhibitors of human glycinamide ribonucleotide transformylase and of aminoimidazole carboxamide ribonucleotide transformylase are designed, synthesized, and characterized.

  设计、合成和表征了对人类甘氨酰核糖核苷转甲基酶和氨基咪唑甲酰核糖核苷转甲基酶具有强效抑制作用的人类抑制剂。
• [EN] TARGETED RADIOPHARMACEUTICALS FOR THE DIAGNOSIS AND TREATMENT OF PROSTATE CANCER<br/>[FR] PRODUITS RADIOPHARMACEUTIQUES CIBLÉS POUR LE DIAGNOSTIC ET LE TRAITEMENT DU CANCER DE LA PROSTATE
  申请人：BAYER AS

  公开号：WO2021013978A1

  公开（公告）日：2021-01-28

  A compound of general formula (I): wherein: n is 1, 2 or 3; R1, R2, R3 and R4, independently represent OH or Q; and 20 Q represents a tissue-targeting moeity selected from the group consisting of or a stereoisomer, a hydrate, a solvate, or a salt thereof, or a mixture of same, methods of preparing said compounds, intermediate compounds useful for preparing said compounds, pharmaceutical compositions and combinations comprising said compounds and the use of said 25 compounds for manufacturing pharmaceutical compositions for the treatment or prophylaxis of diseases, in particular of soft tissue diseases, as a sole agent or in combination with other active ingredients.

  通用式(I)的化合物：其中：n为1、2或3；R1、R2、R3和R4独立地代表OH或Q；Q代表从群组中选择的组织靶向基团，或其立体异构体、水合物、溶剂合物、盐或其混合物，制备所述化合物的方法，用于制备所述化合物的中间化合物，包含所述化合物的药物组合物和组合物，以及用于制造用于治疗或预防疾病的药物组合物的所述化合物的用途，特别是软组织疾病的治疗或预防，作为唯一药剂或与其他活性成分结合使用。
• New Caged Coumarin Fluorophores with Extraordinary Uncaging Cross Sections Suitable for Biological Imaging Applications
  作者：YuRui Zhao、Quan Zheng、Kenneth Dakin、Ke Xu、Manuel L. Martinez、Wen-Hong Li

  DOI：10.1021/ja036958m

  日期：2004.4.1

  efficiency of the coumarin cage and that the photonic energy absorbed by coumarin was utilized efficiently to photolyze the NPE group. Future explorations of this type of "substrate-assisted photolysis" may yield other cages of high uncaging cross sections. For cellular imaging applications, we prepared a cell permeable and caged coumarin fluorophore, NPE-HCCC2/AM (10), which can be loaded into fully intact

  光笼荧光分子是用于跟踪生物系统中具有高时空分辨率的分子动力学的重要研究工具。我们设计并合成了一类新的笼状香豆素荧光团。这些香豆素笼在紫外线光解后显示出超过 200 倍的荧光增强。值得注意的是，1-（2-硝基苯基）乙基（NPE）-笼状香豆素的非笼状横截面在 365 nm 的波长下为 6600，比之前描述的笼状荧光团高约 2 个数量级。光解反应的产物分析表明，NPE 笼状香豆素完全转化为 2-亚硝基苯乙酮和母体香豆素，表明光解的机制遵循已知的 2-硝基苄基光化学反应途径。我们还测量了 NPE 笼状香豆素 2a 和 5 在 740 nm 处的双光子解笼锁截面接近 1 Goeppert-Mayer (GM)。机械研究与双光子解笼数据一起表明，香豆素部分作为天线来提高香豆素笼的光收集效率，并且香豆素吸收的光子能量被有效地用于光解 NPE 基团。未来对这种“基材辅助光解”的探索可能会产生其他具有高非笼
• Chiral Arylated Amines via C−N Coupling of Chiral Amines with Aryl Bromides Promoted by Light
  作者：Geyang Song、Liu Yang、Jing‐Sheng Li、Wei‐Jun Tang、Wei Zhang、Rui Cao、Chao Wang、Jianliang Xiao、Dong Xue

  DOI：10.1002/anie.202108587

  日期：2021.9.20

  molecular Ni catalysis driven by light, which enables stereoretentive C-N coupling of optically active amines, amino alcohols, and amino acid esters with aryl bromides, with no need for any external photosensitizer. The method is effective for a wide variety of coupling partners, including those bearing functional groups sensitive to bases and nucleophiles, thus providing a viable alternative to accessing

  Buchwald-Hartwig CN 偶联反应已在有机合成中得到广泛应用。在过去二十年左右的时间里，已经引入了许多改进的催化剂，现在可以很容易地使用各种胺和芳基亲电试剂。然而，缺乏可用于偶联各种手性胺和芳基卤而不会侵蚀过量对映体 ( ee) 的方案）。本文报道了一种基于光驱动的分子 Ni 催化的方法，该方法能够使旋光胺、氨基醇和氨基酸酯与芳基溴进行立体保留 CN 偶联，无需任何外部光敏剂。该方法对多种偶联伙伴有效，包括那些带有对碱和亲核试剂敏感的官能团的偶联伙伴，从而为获取合成重要的手性N-芳基胺、氨基醇和氨基酸酯提供了可行的替代方案。92 个例子证明了它的可行性，ee高达 99% 。
• ANTIBODY DRUG CONJUGATES (ADCS) AND ANTIBODY PRODRUG CONJUGATES (APDCS) WITH ENZYMATICALLY CLEAVABLE GROUPS
  申请人：Bayer Pharma Aktiengesellschaft

  公开号：US20180169256A1

  公开（公告）日：2018-06-21

  The present invention relates to novel binder-prodrug conjugates (APDCs) where binders are conjugated with inactive precursor compounds of kinesin spindle protein inhibitors, and to antibody-drug conjugates ADCs and to processes for producing these APDCs and ADCs.

  这项发明涉及新型结合物-前药偶联物（APDCs），其中结合物与动力蛋白纺锤体抑制剂的非活性前体化合物偶联，以及抗体药物偶联物ADCs以及制备这些APDCs和ADCs的方法。